Jennifer Lynn Ziolkowski

This profile gathers the share dealings of Jennifer Lynn Ziolkowski across 2 companies, led by Solid Biosciences Inc. and Vigil Neuroscience, Inc. In total, 8 filings cover trades dated from 11 March 2020 to 5 August 2025.

In open-market terms, that means 1 purchase worth €14k on one side and 2 sales worth €25k on the other. On balance, insiders were net sellers of €11k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants and 2 option exercises.

On 5 August 2025 came the latest disclosure, a transaction in Vigil Neuroscience, Inc. The last purchase on record was published on 4 May 2022, which is 1,634 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.